Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-10 Sale |
2021-02-12 6:36 pm |
Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director |
8,400 | $25.3 | $212,555 | 10,900 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-01 Option Award |
2025-04-03 11:56 am |
N/A 2035-03-31 |
Metagenomi Inc. | MGX | Noonberg Sarah B. Chief Medical Officer |
98,000 | $0 | 198,374 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-20 4:27 pm |
N/A 2034-06-18 |
MARINUS PHARMACEUTICALS INC. | MRNS | Noonberg Sarah B. Director |
12,750 | $0 | 24,550 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-17 2:36 pm |
N/A 2034-06-14 |
Neurogene Inc. | NGNE | Noonberg Sarah B. Director |
7,700 | $0 | 7,700 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 8:47 pm |
N/A 2034-03-31 |
Metagenomi Inc. | MGX | Noonberg Sarah B. Chief Medical Officer |
300,638 | $0 | 343,249 (Direct) |
View |
Ownership |
2024-02-08 7:26 pm |
N/A N/A |
Metagenomi Inc. | MGX | Noonberg Sarah B. Chief Medical Officer |
0 | $0 | 42,611 (Direct) |
View |
| 2024-01-18 Option Award |
2024-01-19 4:28 pm |
N/A 2034-01-18 |
MARINUS PHARMACEUTICALS INC. | MRNS | Noonberg Sarah B. Director |
25,500 | $0 | 32,700 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-18 6:56 pm |
N/A 2034-01-16 |
Neurogene Inc. | NGNE | Noonberg Sarah B. Director |
15,400 | $0 | 15,400 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 4:26 pm |
N/A 2033-06-07 |
Neoleukin Therapeutics Inc. | NLTX | Noonberg Sarah B. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-05-16 Option Award |
2023-05-17 9:08 pm |
N/A 2033-05-16 |
MARINUS PHARMACEUTICALS INC. | MRNS | Noonberg Sarah B. Director |
39,600 | $0 | 39,600 (Direct) |
View |
| 2023-01-16 Option Award |
2023-01-18 8:03 pm |
N/A 2033-01-15 |
Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 4:01 pm |
N/A 2032-05-26 |
Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-05-12 Option Award |
2022-05-16 6:24 pm |
N/A 2032-05-11 |
Neoleukin Therapeutics Inc. | NLTX | Noonberg Sarah B. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-05-27 Option Award |
2021-05-28 6:43 pm |
N/A 2031-05-26 |
Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2021-05-11 Option Award |
2021-05-13 5:37 pm |
N/A 2031-05-10 |
Neoleukin Therapeutics Inc. | NLTX | Noonberg Sarah B. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 6:36 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director |
8,400 | $6.98 | 10,900 (Direct) |
View |
| 2021-02-10 Exercise |
2021-02-12 6:36 pm |
N/A 2028-05-28 |
Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director |
8,400 | $0 | 10,900 (Direct) |
View |
| 2020-05-28 Option Award |
2020-05-29 6:16 pm |
N/A 2030-05-27 |
Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-05-05 Option Award |
2020-05-07 4:26 pm |
N/A 2030-05-05 |
Neoleukin Therapeutics Inc. | NLTX | Noonberg Sarah B. Director |
25,000 | $0 | 25,000 (Direct) |
View |